Irritable Bowel Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Irritable Bowel Syndrome, including details on treatment, symptoms, digestion, nutrition, diet, drugs.

Volume 2 (2005), Issue 5 (May)

1. Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality?
   Gastroenterol Clin North Am, 34(2): 337-54. [Abstract] [Full-text]
2. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.
   Gastroenterol Clin North Am, 34(2): 319-35, viii. [Abstract] [Full-text]
3. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment.
   Gastroenterol Clin North Am, 34(2): 305-17. [Abstract] [Full-text]
4. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments.
   Gastroenterol Clin North Am, 34(2): 281-303. [Abstract] [Full-text]
5. Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder?
   Gastroenterol Clin North Am, 34(2): 271-9. [Abstract] [Full-text]
6. The pathogenesis of bloating and visible distension in irritable bowel syndrome.
   Gastroenterol Clin North Am, 34(2): 257-69. [Abstract] [Full-text]
7. The role of food intolerance in irritable bowel syndrome.
   Gastroenterol Clin North Am, 34(2): 247-55. [Abstract] [Full-text]
8. Is irritable bowel syndrome a low-grade inflammatory bowel disease?
   Gastroenterol Clin North Am, 34(2): 235-45, vi-vii. [Abstract] [Full-text]
9. Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon.
   Gastroenterol Clin North Am, 34(2): 221-33, vi. [Abstract] [Full-text]
10. Diagnosis of irritable bowel syndrome.
    Gastroenterol Clin North Am, 34(2): 205-20, vi. [Abstract] [Full-text]
11. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors.
    Gastroenterol Clin North Am, 34(2): 189-204. [Abstract] [Full-text]
12. Definition and classification of irritable bowel syndrome: current consensus and controversies.
    Gastroenterol Clin North Am, 34(2): 173-87. [Abstract] [Full-text]
13. Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice.
    Am J Physiol Gastrointest Liver Physiol, 288(6): G1266-73. [Abstract] [Full-text]
14. Are cardiac syndrome X, irritable bowel syndrome and reflex sympathetic dystrophy examples of lateral medullary ischaemic syndromes?
    Med Hypotheses, 65(1): 145-8. [Abstract] [Full-text]
15. Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
    Med Hypotheses, 65(1): 97-102. [Abstract] [Full-text]
16. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis.
    Pain, 115(3): 398-409. [Abstract] [Full-text]
17. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms.
    Pain, 115(3): 338-47. [Abstract] [Full-text]
18. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
    Neurogastroenterol Motil, 17(3): 415-22. [Abstract] [Full-text]
19. The placebo effect in irritable bowel syndrome trials: a meta-analysis.
    Neurogastroenterol Motil, 17(3): 332-40. [Abstract] [Full-text]
20. Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?
    Neurogastroenterol Motil, 17(3): 317-24. [Abstract] [Full-text]

© 2004-2008 Irritable Bowel Syndrome Research Today. All Rights Reserved.